Moreover, stimulation of Vδ1 T cells with IL-2 or IL-15 in vitro induces NKp30 and NKp44, augmenting Vδ1 anti-tumor activity against various leukemias [1, 21, 26]. Here, IL2 is linked to neoplasm.